Innoviva, Inc. (INVA)
Largest Insider Buys in Sector
INVA Stock Price History Chart
INVA Stock Performance
About Innoviva, Inc.
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has …
Insider Activity of Innoviva, Inc.
Over the last 12 months, insiders at Innoviva, Inc. have bought $0 and sold $0 worth of Innoviva, Inc. stock.
On average, over the past 5 years, insiders at Innoviva, Inc. have bought $4.38M and sold $130.77M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 62,000 shares for transaction amount of $814,196 was made by DENNER ALEXANDER J (10 percent owner) on 2023‑06‑15.
List of Insider Buy and Sell Transactions, Innoviva, Inc.
| 2023-11-15 | Sale | Chief Accounting Officer | 10,994 0.0173% | $13.99 | $153,810 | +15.23% | ||
| 2023-06-15 | 10 percent owner | 62,000 0.0912% | $13.13 | $814,196 | +11.20% | |||
| 2023-06-06 | 10 percent owner | 8,000 0.0118% | $13.05 | $104,384 | +10.38% | |||
| 2023-06-05 | 10 percent owner | 7,000 0.0102% | $13.04 | $91,297 | +9.09% | |||
| 2023-05-30 | 10 percent owner | 120,000 0.1775% | $13.01 | $1.56M | +7.09% | |||
| 2023-05-26 | 10 percent owner | 30,000 0.0442% | $13.12 | $393,729 | +5.71% | |||
| 2023-05-25 | 10 percent owner | 50,000 0.0735% | $13.09 | $654,330 | +5.62% | |||
| 2023-05-19 | 10 percent owner | 36,000 0.0531% | $13.48 | $485,147 | +1.71% | |||
| 2023-05-18 | 10 percent owner | 10,000 0.0146% | $13.05 | $130,538 | +3.77% | |||
| 2023-05-17 | 10 percent owner | 50,000 0.0736% | $13.07 | $653,690 | +4.46% | |||
| 2023-05-11 | 10 percent owner | 290,000 0.4246% | $12.34 | $3.58M | +9.90% | |||
| 2023-03-10 | Chief Executive Officer | 3,000 0.0045% | $10.87 | $32,603 | +22.61% | |||
| 2021-08-20 | Sale | Chief Accounting Officer | 1,129 0.0016% | $15.89 | $17,940 | +3.07% | ||
| 2021-08-19 | Sale | Chief Accounting Officer | 2,802 0.004% | $16.02 | $44,888 | +2.50% | ||
| 2021-05-24 | director | 10,000 0.0112% | $13.46 | $134,619 | +21.34% | |||
| 2021-05-21 | director | 10,000 0.0111% | $12.97 | $129,670 | +24.75% | |||
| 2021-05-20 | Sale | 10 percent owner | 32.01M 33.288% | $12.25 | $392.06M | +23.35% | ||
| 2020-02-24 | Sale | Chief Accounting Officer | 2,954 0.003% | $14.78 | $43,660 | -14.60% | ||
| 2019-02-27 | director | 15,000 0.0148% | $15.90 | $238,500 | -13.22% | |||
| 2019-02-26 | Sale | Chief Accounting Officer | 5,617 0.0055% | $16.00 | $89,872 | -13.92% |
Insider Historical Profitability
| DENNER ALEXANDER J | 10 percent owner | 7277000 11.6244% | $17.84 | 10 | 0 | +6.89% |
| Winningham Rick E | Chief Executive Officer | 690106 1.1024% | $17.84 | 1 | 10 | +19.65% |
| Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 446274 0.7129% | $17.84 | 1 | 9 | <0.0001% |
| GLICK MARTY | Executive VP, Finance and CFO | 267805 0.4278% | $17.84 | 1 | 0 | <0.0001% |
| BLUM LEONARD M | Sr VP, Chief Comm. Officer | 158618 0.2534% | $17.84 | 3 | 0 | +41.56% |
Institutional Investor Ownership
| BlackRock | $154.57M | 16.24 | 10.14M | -2.03% | -$3.2M | <0.01 | |
| Sarissa Capital Management LP | $110.9M | 11.65 | 7.28M | 0% | +$0 | 19.4 | |
| The Vanguard Group | $95.8M | 10.07 | 6.29M | -6.35% | -$6.5M | <0.01 | |
| Franklin Templeton Investments | $95.58M | 10.04 | 6.27M | +13,628.29% | +$94.88M | 0.03 | |
| Dimensional Fund Advisors | $70.31M | 7.39 | 4.61M | +2.13% | +$1.47M | 0.02 |